Effects of age on prognosis with imatinib mesylate therapy for patients with Philadelphia chromosome-positive chronic myelogenous leukemia-Reference-Cited by-同舟云学术

Effects of age on prognosis with imatinib mesylate therapy for patients with Philadelphia chromosome-positive chronic myelogenous leukemia

Published:2003-09-08 Issue:6 Volume:98 Page:1105-1113
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Cortes Jorge,Talpaz Moshe,O'Brien Susan,Giles Francis,Beth Rios Mary,Shan Jianquin,Faderl Stefan,Garcia-Manero Guillermo,Ferrajoli Alessandra,Wierda William,Kantarjian Hagop

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference27 articles.

1. Chronic myelogenous leukemia: a multivariate analysis of the associations of patient characteristics and therapy with survival

2. Proposal for a simple synthesis prognostic staging system in chronic myelogenous leukemia

3. Prognostic discrimination in "good-risk" chronic granulocytic leukemia

4. A New Prognostic Score for Survival of Patients With Chronic Myeloid Leukemia Treated With Interferon Alfa Writing Committee for the Collaborative CML Prognostic Factors Project Group

Cited by 82 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chronic Myeloid Leukemia in Adolescents and Young Adults: Clinicopathological Variables and Outcomes;Oncology;2024-07-16

2. Impact of age and comorbidities on the efficacy and tolerability of bosutinib in previously treated patients with chronic myeloid leukemia: results from the phase 4 BYOND study;Leukemia;2023-11-25

3. Comparison of Clinicopathological Parameters, and Treatment Responses in Younger and Older Chronic Myeloid Leukaemia Patients Treated with Imatinib;NOVEMBER 2023;2023-11-13

4. Prognosis in Chronic Myeloid Leukemia: Baseline Factors, Dynamic Risk Assessment and Novel Insights;Cells;2023-06-23

5. Efficacy and safety of nilotinib as frontline treatment in elderly (> 65 years) chronic myeloid leukemia patients outside clinical trials;Annals of Hematology;2023-04-20